Mini-Intestines reveal why a key drug fails some kids
NCT ID NCT07400783
First seen Feb 10, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study looks at why children with short bowel syndrome respond differently to the drug teduglutide. Researchers will grow tiny, lab-made intestines (organoids) from tissue samples taken during routine surgery. They will then treat these mini-intestines with teduglutide in the lab to see how they change. The goal is to find biological clues that could help doctors personalize treatment in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aou Meyer IRCSS
RECRUITINGFlorence, Florence, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.